Drug Shortage Report for ENABLEX

Last updated on 2019-01-03 History
Report ID 68878
Drug Identification Number 02273217
Brand name ENABLEX
Common or Proper name darifenacin
Company Name SEARCHLIGHT PHARMA INC
Active Ingredient(s) DARIFENACIN
Strength(s) 7.5MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size Bottles of 100
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-12-07
Actual start date
Estimated end date 2019-01-02
Actual end date 2019-01-02
Shortage status Resolved
Updated date 2019-01-03
Company comments Delay in quality release of the product, limited inventory is available. We anticipate meeting demand once the next lot is released. For more information, please contact Methapharm at 1-800-287-7686, sales@methapharm.com, or fax 519-751-9149.
Health Canada comments
Contact Address 1600 RUE NOTRE DAME OUEST, SUITE 312
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-01-03 English Compare
v10 2019-01-02 French Compare
v9 2019-01-02 English Compare
v8 2018-12-19 French Compare
v7 2018-12-19 English Compare
v6 2018-12-18 French Compare
v5 2018-12-18 English Compare
v4 2018-12-08 English Compare
v3 2018-12-07 French Compare
v2 2018-12-07 English Compare
v1 2018-12-07 English Compare